Jean is a biologist who studys Gemcitabine plus cisplatinum which was shown to exert comparable activity in addition to a different toxicity proï¬le when compared to the methotrexate, vinblastine, doxorubicin, cis-platinum (MVAC) regimen in patients with advanced bladder cancer. Accelerated MVAC (aMVAC, the four drugs being administered every two weeks with granulocyte colony-stimulating issue (G-CSF)) is better tolerated than conventional MVAC, with a trend for improved process. My websites: Mycophenolate mofetil CellCept |